| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | Makio Ishiguro | |
| Shigeyuki Matsui | |||
| Tohru Kokubo | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake | Q24538184 | ||
| Annals of clinical research | Q27709013 | ||
| Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time | Q28366938 | ||
| The Path to Personalized Medicine | Q29541502 | ||
| Population and individual bioequivalence: lessons from real data and simulation studies | Q30658519 | ||
| A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis | Q30669346 | ||
| Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head | Q30670986 | ||
| A physiological model for the estimation of the fraction dose absorbed in humans. | Q33980119 | ||
| Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption | Q34358635 | ||
| Statistical analysis of the lactulose/breath hydrogen test in the measurement of orocaecal transit: its variability and predictive value in assessing drug action | Q34391636 | ||
| Modulation of orocaecal transit time by hypnosis | Q34394528 | ||
| Intestinal transit in anxiety and depression | Q34410065 | ||
| Evaluation of gastrointestinal motility using the hydrogen breath test | Q34446763 | ||
| Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndrome | Q34494258 | ||
| Influence of orocaecal transit time on hydrogen excretion after carbohydrate malabsorption | Q34531955 | ||
| Prolonged small-intestinal transit time in cystic fibrosis | Q34995757 | ||
| Small intestinal bacterial overgrowth: a comprehensive review | Q34996846 | ||
| Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms | Q36151612 | ||
| Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group | Q36790212 | ||
| Bioavailability and bioequivalence: focus on physiological factors and variability. | Q37190484 | ||
| Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. | Q37432284 | ||
| Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption | Q37764992 | ||
| The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation | Q37908672 | ||
| Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial | Q39466559 | ||
| Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit | Q41954671 | ||
| Effect of aerobic exercise on mouth-to-cecum transit time. | Q43495346 | ||
| Effects of Subcutaneous Methylnaltrexone on Morphine-Induced Peripherally Mediated Side Effects: A Double-Blind Randomized Placebo-Controlled Trial | Q43830121 | ||
| Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time | Q44331515 | ||
| Orocecal transit delay in obese patients | Q44636799 | ||
| Oro-cecal transit time: influence of a subsequent meal | Q44939189 | ||
| Meal-induced acceleration of tablet transit through the human small intestine | Q46266107 | ||
| Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans | Q46438870 | ||
| The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time | Q48741303 | ||
| Clonidine prolongs human small intestine transit time: use of the lactulose-breath hydrogen test | Q48943560 | ||
| The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease | Q50172530 | ||
| Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis | Q51608412 | ||
| Hydrogen breath test assessment of orocecal transit time: comparison with barium meal study. | Q51623696 | ||
| Effect of erythromycin on the oro-caecal transit time in man. | Q54566953 | ||
| Absorption of wheat starch in patients resected for left-sided colonic cancer | Q67584697 | ||
| Small intestinal transit in diabetics | Q67862989 | ||
| The effect of red and black pepper on orocecal transit time | Q68112490 | ||
| Oral naloxone antagonizes loperamide-induced delay of orocecal transit | Q69126468 | ||
| Effect of drugs on oro-caecal transit time assessed by the lactulose/breath hydrogen method | Q69468132 | ||
| Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time | Q69502689 | ||
| Effect of altering small bowel transit time on sustained release theophylline absorption | Q69724003 | ||
| Scintigraphic determination of small intestinal transit time: comparison with the hydrogen breath technique | Q70323885 | ||
| Limitations of indirect methods of estimating small bowel transit in man | Q70344615 | ||
| Effect of trospium chloride on gastrointestinal motility in humans | Q70709936 | ||
| Determinants of prolonged oral cecal transit time during late phase pregnancy | Q71679007 | ||
| Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome | Q72077278 | ||
| Evaluation of oro-coecal transit time: a comparison of the lactose-[13C, 15N]ureide 13CO2- and the lactulose H2-breath test in humans | Q73046170 | ||
| Gluten-free diet normalizes mouth-to-cecum transit of a caloric meal in adult patients with celiac disease | Q73867388 | ||
| The effect of dose and osmolality of lactulose on the oral-caecal transit time determined by the hydrogen breath test and the reproducibility of the test in normal subjects | Q93689956 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastrointestinal transit | Q70715940 |
| P304 | page(s) | 402-411 | |
| P577 | publication date | 2012-09-28 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Meta-analysis of oro-cecal transit time in fasting subjects | |
| Meta-analysis of Oro-cecal Transit Time in Fasting Subjects | |||
| P478 | volume | 30 |
Search more.